John Naftzger

John Naftzger

Corporate Officer/Principal at
Dyer Ellis & Joseph

Net worth: 609 961 $ as of 31/07/2026

59 year
Health Technology
Consumer Services
Commercial Services

Profile

John Christopher Naftzger currently works at Dyer Ellis & Joseph, as Associate.
Mr. Naftzger also formerly worked at Nabriva Therapeutics Plc, as CEO, Secretary & General Counsel in 2023, Chesapeake Corp., as Assistant Secretary & Assistant General Counsel in 2009, Koch Industries LLC, as Senior Counsel from 2006 to 2007, Unilife Corp., as Secretary, Chief Compliance Officer & VP from 2010 to 2014, Blank Rome LLP, as Partner, Unilife Medical Solutions, Inc., as Secretary, Chief Compliance Officer & VP, Nabriva Therapeutics Plc, as Vice President & Deputy General Counsel from 2017 to 2020, Krystal Biotech, Inc., as Secretary & Chief Legal Officer from 2020 to 2021, and Arbutus Biopharma Corp., as Secretary & Chief Compliance Officer from 2023 to 2025.
Mr. Naftzger received his undergraduate degree from Hampden-Sydney College, graduate degree from Willamette University, and graduate degree from Willamette University College of Law.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/02/2025 140,544 ( 0.07% ) 609 961 $ 31/07/2026

John Naftzger active positions

CompaniesPositionStart
Corporate Officer/Principal -

Former positions of John Naftzger

CompaniesPositionEnd
ARBUTUS BIOPHARMA CORPORATION Compliance Officer 28/03/2025
NABRIVA THERAPEUTICS PLC Chief Executive Officer 07/07/2023
KRYSTAL BIOTECH, INC. General Counsel 01/05/2021
NABRIVA THERAPEUTICS PLC Corporate Officer/Principal 01/01/2020
Corporate Officer/Principal 01/05/2009
See the detail of John Naftzger's experience

Training of John Naftzger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

55

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Consumer Non-Durables

Energy Minerals

Health Technology

Health Technology

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology